Episode 9 - NanoSyrinx: Targeted Drug Delivery with Protein Nanosyringes

NanoSyrinx, a spin out from the University of Warwick, are using viruses to help inject therapeutics directly into the interior of cells, revolutionising how medicines are administered on a nanoscopic scale. Ben talks to their CEO Dr Joe Healey about their bacteria based platform, the recent seed investment raise of £6m and how his interest in being a CEO evolved. 

Recorded as part of a live Scientist to CEO event